GSK Stock
GSK plc
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- United Kingdom
- CEO
- Luke Victor Miels
- Employees
- 66,841
- Market cap
- $99.2 B
- IPO
- 28/03/1980
- Web
- www.gsk.com
GSK plc is a global healthcare entity headquartered in London. Founded in 1715, the company focuses on the research, development, and manufacturing of a wide array of medical solutions designed to prevent and treat illnesses. The operations are organized into two key divisions, namely Commercial Operations and Total…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
GSK stock: price history
1D
+1.0%
1W
+6.5%
1M
-1.6%
6M
-15.1%
YTD
+1.0%
1Y
+13.1%
2Y
+26.3%
5Y
+26.9%
10Y
+18.8%
Next earnings date
Next earnings date
28/10/2026 (in 11 days)
Volatility around earnings
~37% stronger price swings than usual
Ask the agents about GSK
Analyst assessment of GSK
PRICE TARGET LOW
US$60.00
CONSENSUS
US$60.00
MEDIAN
US$60.00
PRICE TARGET HIGH
US$60.00
0
STRONG BUY
9
BUY
16
HOLD
4
SELL
0
STRONG SELL
29
TOTAL · Hold
As of: 06/01/2026
GSK stock metrics
P/E
15.52
P/B
4.24
EV/EBITDA
8.4
RETURN ON EQUITY
2.5%
NET MARGIN
5.2%
DEBT/EQUITY
1.03
DIVIDEND YIELD
3.7%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
96.9%
FLOAT SHARES
1,941,211,185
AVG. DAILY VOLUME (30D)
4,640,198
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: +1.0%
Forums (Reddit)
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about GSK stock
What does GSK do?
GSK plc is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in United Kingdom.
The CEO is Luke Victor Miels, the company employs around 66,841 people.
The IPO was on 28/03/1980; the stock trades on NYSE under the ticker GSK.
What do analysts say about GSK stock?
29 analysts rate the stock, the consensus is Hold (as of 06/01/2026).
The average price target is US$60.00, ranging from US$60.00 to US$60.00, with a median of US$60.00.
This is an external assessment, not a statement by Market Jury.
When does GSK report next?
The next earnings date is 28/10/2026.
Around past earnings, price swings were roughly 37% stronger than usual.
Does GSK pay a dividend?
Yes. The last dividend was US$0.45 per share, ex-date 14/08/2026, paid on 08/10/2026.
The dividend yield is 3.7% (as of 30/06/2026).
Which stocks are comparable to GSK?
Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Roche Holding, Amgen, Gilead Sciences and Pfizer.
How can I get GSK stock analyzed?
Clicking "Analyze stock" lets five strategies assess GSK against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.